It has been over a year since I first read about goat serum used to enhance nerve activity in MS.
For two years the MS Society has been asking for clinical trials to prove safety and efficacy before it is offered to the public. But there are 'roadshows' actively promoting the goat serum drug Aimspro.
Now there is concern that UK MSers are being seduced into buying the expensive treatment that has not been proven to be effective in treating MS. Daval, maker of Aimspro, is under investigation by the Medicines and Healthcare Products Regulatory Agency.
It all sounds pretty sleezy . . but, wait. There is an update. Two clinical trials are scheduled to start in October and a third is awaiting approval. They are targeting patients who have already proved resistant to current treatments. Maybe this goat serum is not so bad after all.
Research and Development are now the focus of Daval International. We'll, know more when the tests have been completed, but it sounds promising.